HistoGeneX
Cap, clia and belac-accredited laboratory.
Financials
Estimates*
EUR | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Revenues | <1m | <1m | - | - |
% growth | - | 25 % | - | - |
Profit | 1.2m | 5.0m | <1m | <1m |
% profit margin | 162 % | 524 % | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Spinout | ||
N/A | Growth Equity VC | ||
* | N/A | Merger | |
Total Funding | - |
Related Content
Recent News about HistoGeneX
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by HistoGeneX
EditACQUISITION by HistoGeneX Jan 2021